Skip to main content
Equibles
COLL logo

COLL · Collegium Pharmaceutical, Inc

Track COLL — free

Use COLL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$23.53 -0.17 (-0.72%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$766.03M
Shares
32.56M

COLL metrics

87 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$23.53
Market cap
$766.03M

Price action

19 metrics
Price change (1W)
-7.2%
Price change (30D)
-20.2%
Price change (3M)
-29.5%
Price change (6M)
-36.9%
Price change (YTD)
-49.2%
Price change (1Y)
-40.0%
Trailing year
Price change (5Y)
+16.8%
52-week high
$49.84
52-week low
$23.53
Change from 52-week high
-52.8%
Change from 52-week low
+0.0%
Annualized volatility
44.6%
Beta
0.4
RSI (14D)
24.5
Price vs SMA 50
-26.1%
Price vs SMA 200
-38.2%
Avg volume (3M)
597,165
Relative volume
1.5
Average dollar volume
$18.31M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
32.56M

Valuation

12 metrics
P / E (TTM)
19.0
Trailing earnings · reciprocal yield 5.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 105.5%
P / book
2.5
reciprocal yield 40.7%
FCF yield
42.9%
TTM · current market cap
Buyback yield
6.5%
P / FCF
2.3
reciprocal yield 42.9%
P / operating cash flow
2.3
reciprocal yield 43.1%
Earnings yield
6.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.7×
reciprocal yield 57.6%
EV / revenue historical average (5Y)
1.7×
reciprocal yield 57.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
60.0%
Operating margin
19.5%
Trailing 12 months
Net margin
5.9%
Gross profit (TTM)
$485.09M
Operating profit (TTM)
$157.44M
Net income (TTM)
$47.91M
Trailing 12 months
Diluted EPS (TTM)
$1.24
FCF margin
40.6%
Effective tax rate
38.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$21.42
Gross profit per diluted share (TTM)
$12.80
Operating profit per diluted share (TTM)
$3.98
EBITDA per diluted share (TTM)
$1.13
Net income per diluted share (TTM)
$1.12
Operating cash flow per diluted share (TTM)
$8.68
Free cash flow per diluted share (TTM)
$8.64
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$0.09
Stock compensation per diluted share (TTM)
$1.21
Book value per share
$-88.80

Growth

11 metrics
Revenue growth YoY
+6.3%
Year over year
Net income growth YoY
-225.6%
Revenue (TTM)
$808.21M
Trailing 12 months
EPS growth YoY
-235.3%
Shares change YoY
-16.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+18.9%
Revenue CAGR (5Y)
+20.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+17.9%
FCF CAGR (3Y)
+38.8%
FCF CAGR (5Y)
+30.0%

Quality

14 metrics
Return on equity
15.4%
Return on assets
2.2%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$39.65M
Free cash flow (TTM)
$328.28M
Quick ratio
0.8
Interest coverage
2.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$129.47M
Total assets
$2.14B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$329.92M
Capital expenditures (TTM)
$1.64M
R&D (TTM)
$5.59M
SG&A (TTM)
$327.69M
Stock compensation (TTM)
$44.93M
R&D / revenue
—
Stock compensation / revenue
5.6%

Ownership (13F)

3 metrics
13F filers
281
13F filer change QoQ
+13
Institutional ownership
120.5%

Short interest

3 metrics
Short interest
20.0%
Latest settlement · 6.7 days to cover
Days to cover
6.7d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1267565 CUSIP 19459J104 13F (30d) 196 filings 195 filers Visit website Investor relations